These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 26666761

  • 1. Effect of Compound Zhebei Granule () combined with chemotherapy on surface markers of leukemia stem cell in patients with acute myeloid leukemia.
    Wang J, Lai ZL, Chen XY, Li DY, Zhang YY, Ma W, Chu YT, Shi FQ, Yang L, Hou L.
    Chin J Integr Med; 2016 Jun; 22(6):438-44. PubMed ID: 26666761
    [Abstract] [Full Text] [Related]

  • 2. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A, Gillis D, Lewis I.
    J Hematol Oncol; 2016 Jul 27; 9(1):61. PubMed ID: 27465508
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CD33, CD96 and Death Associated Protein Kinase (DAPK) Expression Are Associated with the Survival Rate and/or Response to the Chemotherapy in the Patients with Acute Myeloid Leukemia (AML).
    Jiang Y, Xu P, Yao D, Chen X, Dai H.
    Med Sci Monit; 2017 Apr 09; 23():1725-1732. PubMed ID: 28391288
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemia.
    Kersten B, Valkering M, Wouters R, van Amerongen R, Hanekamp D, Kwidama Z, Valk P, Ossenkoppele G, Zeijlemaker W, Kaspers G, Cloos J, Schuurhuis GJ.
    Br J Haematol; 2016 Apr 09; 173(2):219-35. PubMed ID: 26814163
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
    Mohammadi S, Ghaffari SH, Shaiegan M, Zarif MN, Nikbakht M, Akbari Birgani S, Alimoghadam K, Ghavamzadeh A.
    Life Sci; 2016 May 01; 152():190-8. PubMed ID: 27063991
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tracing Leukemia Stem Cells and Their Influence on Clinical Course of Adult Acute Myeloid Leukemia.
    Kandeel EZ, El Sharkawy N, Hanafi M, Samra M, Kamel A.
    Clin Lymphoma Myeloma Leuk; 2020 Jun 01; 20(6):383-393. PubMed ID: 32201129
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of CD200 and CD123 is a major influential factor in the clinical course of pediatric acute myeloid leukemia.
    Kandeel EZ, Madney Y, Eldin DN, Shafik NF.
    Exp Mol Pathol; 2021 Feb 01; 118():104597. PubMed ID: 33358743
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Changes of Leukemia Stem Cells in Acute Myeloid Leukemia before and after Treatment].
    Lv JT, Yang ZG, Guang YH, Lin ZS, Xiao XX, Liu D, Shi M, Wang WS.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun 01; 26(3):658-664. PubMed ID: 29950200
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Leukemia-associated aberrant immunophenotype in patients with acute myeloid leukemia: changes at refractory disease or first relapse and clinicopathological findings.
    Cui W, Zhang D, Cunningham MT, Tilzer L.
    Int J Lab Hematol; 2014 Dec 01; 36(6):636-49. PubMed ID: 24602197
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Leukemic Stem Cell (CD34+/CD38-/TIM3+) Frequency in Patients with Acute Myeloid Leukemia: Clinical Implications.
    Mohamed MMI, Aref S, Agdar MA, Mabed M, El-Sokkary AMA.
    Clin Lymphoma Myeloma Leuk; 2021 Aug 01; 21(8):508-513. PubMed ID: 33931379
    [Abstract] [Full Text] [Related]

  • 20. Expression of multiple leukemic stem cell markers is associated with poor prognosis in de novo acute myeloid leukemia.
    Yabushita T, Satake H, Maruoka H, Morita M, Katoh D, Shimomura Y, Yoshioka S, Morimoto T, Ishikawa T.
    Leuk Lymphoma; 2018 Sep 01; 59(9):2144-2151. PubMed ID: 29251166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.